Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer: A novel molecular marker?

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 1, 2003, Pages 29-34

  Roddiger, Sandra J ^a   Renneberg, Heiner ^b,c   Martin, Thomas ^a   Tunn, Ulf W ^a   Zamboglou, Nikolaos ^a   Kurek, Rail ^a  

^a Academic Hospital   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

hK2; Molecular staging; RT PCR; Thyroid cancer

Indexed keywords

HUMAN KALLIKREIN 2; KALLIKREIN; MESSENGER RNA; MOLECULAR MARKER; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CHI SQUARE TEST; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; VOLUNTEER;

EID: 0344406972     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0401-y     Document Type: Article

References (37)

1. Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R, Filetti S (1997) Early diagnosis by genetic analysis of differentiated thyroid cancer metastasis in small lymph nodes. J Clin Endocrinol Metab 82:1638-1641
2. Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14:146
3. Aust G, Crisp M, Bosenberg E, Ludgate M, Weetman AP, Paschke R (1998) Transcription of thyroid autoantigens in non-expressing tissues. Exp Clin Endocrinol Diabetes. 106:319-323
4. Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, Maussier L, Salvatori M, Rufini V, Reale F, Romano L, Tallini G, Zelano G, Pontecorvi A (2001) Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer 92:2273-2279
5. Biscolla RP, Cerutti JM, Maciel RM (2000) Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 85:3623-3627
6. Black MH, Magklara A, Obiezu C, Levesque MA, Sutherland DJ, Tindall DJ, Young CY, Sauter ER, Diamandis EP (2000) Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br J Cancer 82:361-367
7. Bojunga J, Roddiger S, Stanisch M, Kusterer K, Kurek R, Renneberg H, Adams S, Lindhorst E, Usadel KH, Schumm-Draeger PM (2000) Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 82:1650-1655
8. Brabant G, Maenhaut C, Kohrle J, Scheumann G, Dralle H, Hoang-Vu C, Hesch RD, von zur Muhlen A, Vassart G, Dumont JE (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7-12
9. Corey E, Corey J (1998) Detection of disseminated prostate cells by reverse transcription polymerase chain reaction (RT-PCR): technical and clinical aspects. Int J Cancer 77:655-673
10. Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ, Vesella RL (1997) Detection of circulating prostate cells by reverse trancriptase polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Urology 50:184-188
11. Curry BJ, Myers K, Hersey P (1998) Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment and recurrence from melanoma. J Clin Oncol 16:1760-1769
12. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482
13. DeMicco C, Kopp F, Vassko V, Grino M (2000) In situ hybridisation and immunohistochemistry study of thyroid peroxidase expression in thyroid tumors. Thyroid 10:109-115
14. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, Lo Gerfo PL (1996) Detection of circulating thyroid cells in peripheral blood. Surgery 120:959-965
15. Fenton C, Anderson JS, Patel AD, Lukes Y, Solomon B, Tuttle RM, Ringel MD, Francis GL (2001) Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant thyroid disease. Pediatr Res 49:429-434
16. Ghossein RA, Rosai J (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:10-16
17. Ghossein RA, Carusone L, Bhattacharya S (1999) Polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate and thyroid carcinomas. Diagn Mol Pathol 8:165-175
18. Haber RS (1998) The diagnosis of recurrent thyroid cancer- a new approach. J Clin Endo Metab 83:4189-4199
19. Kawakami M, Okaneya T, Furihata K, Nishizawa O, Katsuyama E (1997) Detection of prostate cancer cells circulating in peripheral blood by reverse transcriptase polymerase chain reaction. Cancer Res 57:4167-4170
20. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K (1995) Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75:2214-2219
21. Kurek R, Renneberg H, Konrad L, Wennemuth G, Kiani S, Martin T, Aumüller G, Tunn UW (1998) RT-PCR based detection of circulating cancer cells in peripheral blood of prostate cancer patients: expression of PSA, hK2 and PSM in different human tissues - implications for the use as a diagnostic tool. Eur Urol 34 [Suppl]:261-262
22. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD (1997) Comparison of recombinant human thyrotropin administration to thyroid hormone withdrawal for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896
23. Lazar V, Bidart JM, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M (1999) Expression of the Na symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-34
24. Ligabue A, Poggioli MC, Zacchini (1993) A Interference of specific autoantibodies in the assessment of serum thyroglobulin. J Nucl Biol Med 37:273-279
25. Magklara A, Cheung CC, Asa SL, Diamandis EP (2000) Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland. Clin Chim Acta 300:171-180
26. Morris BJ (1989) hGK1: A kallikrein gene expressed in human prostate. Clin Exp Pharmacol Physiol 16:345-351
27. Riegman PH, Vliestra RJ, Suurmeijer L, Cleutjens CB, Trapman J (1992) Characterisation of the human kallikrein locus. Genomics 14:6-11
28. Ringel MD, Ladenson PW, Levine MA (1998) Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid and peripheral blood. J Clin Endocrinol Metab 1998:4435-4442
29. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW (1998) Human kallikrein 2 (hK2) and prostate-specific-antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 35:275-368
30. Roddiger SJ, Bojunga J, Klee V, Stanisch M, Renneberg H, Lindhorst E, Usadel KH, Kusterer K, Schumm-Draeger PM, Kurek R (2002) Detection of thyroid peroxidase mRNA in peripheral blood of patients with maliganant and benign thyroid diseases. J Mol Endocrinol 29 (in press)
31. Savanger F, Rodien P, Reynier P, Rohmer V, Birgorgne JC, Malthiery Y (2002) Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid patients. J Clin Endocrinol Metab 87:635-639
32. Schedlich LJ, Bennets BH, Morris BJ (1987) Primary structure of a human glandular kallikrein gene. DNA 6:429-437
33. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T (1987) Papillary and follicular thyroid cancer - prognostic factors in 1,578 patients. Am J Med 83:479-488
34. Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma K, Amino N (2001) Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer 85:102-106
35. Tallini G, Ghossein R. A, Emanuel J, Gill J, Kinder B, Dimich AB Costa J, Robbins R, Burrow GN, Rosai J (1998) Detection of thyroglobulin, thyroid peroxidase and ret/ptc1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 16:1158-1166
36. Wasserman L, Dreilinger A, Easter D, Wallace A (1999) A seminested RT-PCR assay for her2/neu: initial validation of a new method for the detection of disseminated breast cancer. Mol Diagn 4:21-28
37. Wingo ST, Ringel MD, Anderson JS (1999) Quantitative reverse transcription-PCR measurements of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 45:785-789